9:30am ET
Health and Healthcare
Short Sellers More Selective on Big Pharma Stocks
The short interest data has been released for the May 15 settlement date and for the selected pharmaceutical stocks, short interest is mixed.
ABBV Coverage Page 41
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero, Virtu and More
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, eBay, Rite Aid, TiVo, Yahoo, Valero Energy and Virtu Financial.
9:15am ET
Health and Healthcare
Jefferies Makes Changes to Top Pharmaceutical Stocks to Buy
With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share of attention…
9:50am ET
Health and Healthcare
Short Sellers Keep Strong Bets Against Big Pharma
The April 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest is mixed.
10:00am ET
Health and Healthcare
Huge Buyout Highlights 4 Deutsche Bank Biotech Focus Stocks
In a new report, Deutsche Bank acknowledges that while the industry has shown recent weakness, now may be just the right time to add biotech stocks.
10:50am ET
Health and Healthcare
Top Credit Suisse Major Pharma Stock Picks to Buy
Credit Suisse has released a report that detailed its top picks for pharmaceutical stocks for the rest of 2015.
8:30am ET
Investing
5 Cheap Large Cap Stocks to Buy in an Expensive Stock Market
A new report from Deutsche Bank highlights all of the known risks and focuses in on stocks that are reasonable in a pricey market.
9:10am ET
Health and Healthcare
3 Big Pharmaceutical Stocks Will Have Rising Q1 Earnings
In a new report, Cowen analysts have sights set on three major pharmaceutical stocks that they expect to have rising first-quarter earnings.
8:55am ET
Investing
Should Investors Buy These 4 ‘Bad News’ Stocks for Big Gains?
24/7 Wall St. has found four good examples of blue-chip stocks that got a little tarnished recently for one reason or another, that investors may want to reexamine.
8:20am ET
Health and Healthcare
The Next 3 Likely Biotech Buyout Candidates
Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics acquisition.
10:40am ET
Health and Healthcare
Just How Expensive Is the Pharmacyclics Buyout?
News finally broke late Wednesday that there was an official buyout of Pharmacyclics in the works by AbbVie for $21 billion.
4:45pm ET
Health and Healthcare
Is Express Scripts 2015 Guidance Good Enough For All-Time Highs?
ThinkstockAfter the markets closed Monday, Express Scripts Holding Company (NASDAQ: ESRX) reported its fourth-quarter financial results as $1.39 in earnings per share (EPS) and $26.31 billion in revenue. This is compared to…
9:05am ET
Health and Healthcare
Jefferies 4 Top Pharmaceutical Stocks to Buy
One area that makes sense for growth investors is the large cap pharmaceuticals. Here are some the top pharmaceutical stocks to buy now according to Jefferies.
8:50am ET
Health and Healthcare
Neurocrine Biosciences Announces New Offering
Neurocrine Biosciences has announced that it will have another public offering of its common stock to raise roughly $225 million.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Alcoa, Apple, Deckers, Dish, Pfizer, Petrobras and More
Monday's top analyst upgrades, downgrades and initiations include AbbVie, Alcoa, Apple, Deckers Outdoor, Dish Network, Pfizer and Petrobras.